Ground- and excited-state interactions of2,7,12,17-tetraphenylporphycene with model target biomolecules for type-I photodynamic therapy

Noemí Rubio, Víctor Martínez-Junza, Jordi Estruga, José I. Borrell, Margarita Mora, M. Lluïsa Sagristá, Santi Nonell

Producción científica: Artículo en revista indizadaArtículorevisión exhaustiva

7 Citas (Scopus)

Resumen

Biosubstrate-sensitizer binding is one of the factors that enhances the type-I mechanism over the type-II in the whole photodynamic process. 2,7,12,17-Tetraphenylporphycene (TPPo), a second-generation photosensitizer, is a hydrophobic compound with good photophysical properties for photodynamic therapy applications that has proved its ability for the photoinactivation of different cell lines. Nevertheless, little is known about its mechanism of action. This paper focuses on the study of the interaction/binding of TPPo with different model biomolecules that may favor the type-I mechanism in the overall photodynamic process, including nucleosides, proteins, and phospholipids. Compared with more hydrophilic photosensitizers, it is concluded that TPPo is more likely to undergo type-II (singlet oxygen) than type-I (electron transfer) photodynamic processes in biological environments.

Idioma originalInglés
Páginas (desde-hasta)99-106
Número de páginas8
PublicaciónJournal of Porphyrins and Phthalocyanines
Volumen13
N.º1
DOI
EstadoPublicada - ene 2009

Huella

Profundice en los temas de investigación de 'Ground- and excited-state interactions of2,7,12,17-tetraphenylporphycene with model target biomolecules for type-I photodynamic therapy'. En conjunto forman una huella única.

Citar esto